Our Discovery Services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. In Small Molecules, our services cover Chemistry, Biology, Safety Assessment & Toxicology, and Research Informatics. In Large Molecules, our services cover recombinant DNA engineering, cell line development, hybridoma technology, Next-Generation Sequencing, and protein sciences (purification & crystallography).
What sets us apart in Discovery Services, is our ability to seamlessly connect discovery and development, our target-focused modality, and therapeutic area – agnostic approach. In addition, is our collaborative partnership model, supported by robust logistics, streamlined project management, and cutting-edge IT infrastructure.